Sign in
APMD Stock Price, Chart, Stats & News
Apnimed, Inc.
Save
Apnimed, Inc. (APMD) does not currently pay a dividend.
1.02B
Market cap
–
Current P/E
–
Forward P/E
APMD chart
1M
3M
1Y
5Y
Loading chart...
About
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Similar securities
Based on sector and market capitalization
Report issue